1Astrea G, Schessl J, Clement E, et al. Muscle MRI in FHL1-linked reducing body myopathy. Neuromuscul Dis- ord, 2009, 19(10) : 689-691.
2Ohsawa M, Liewluck T, Ogata K, et al. Familial reduc- ing body myopathy. Brain Dev, 2007, 29 (2) : 112- 116.
3McGrath MJ, Cottle DL, Ngayen MA, et al. Four and a half LIM proteins 1 bind myosin-binding protein C and reg- ulate myosin filament formation and sarcomere assembly. J Biol Chem, 2006, 281(11) : 7666-7683.
4Carpenter S, Karpati G, Holland P. New observations in re- ducing body myopathy. Neurology, 1985, 35 (6) : 818- 827.
5Kiyomoto BH, Murakami N, Kishibayashi J, et al. Reducing bodies in distalmyopathy with rimmed vacuo leformation. Acta Neuropathol (Berl) , 1995, 89(1) : 109-111.
6Liewluck T, Hayashi YK, Ohsawa M, et. al. Unfolded pro- tein response and aggresome formation in hereditary reducing- body myopathy. Muscle Nerve, 2007, 35 (3) : 322-326.
7Betini E, Salviati G, Apollo F, et al. Reducing body myoph- athy and desmin storage in skeletalmuscle: morphological and biochemical findings. Acta Neuropathol ( Berl ) , 1994, 87 (1):106-112.
8Shinde A, Nakano S, Kusaka H, et al. Nucleolar character- istics of reducing bodies in reducing body myopathy. Acta Neuropathol, 2004, 107 (3) : 265 -271.
9Schessl J, Zou Y, McGrath M J, et al. Proteomic identifica- tion of FHL 1 as the protein mutated in human reducing body myopathy J Clin Invest, 2008, 118(3) : 904 -912.
10Ferret I, Carmona M, Blanco R, et al. Involvement of elus-terin and the aggresome in albnormal protein deposits in myofi- brillar myopathies and inclusion body myositis. Brain Panml, 2005, 15(2): 101-108.
